< Back to all Breaking News
GALT
6/30/2020 08:06am
Galectin commences patient enrollment in Phase 2b/3 trial of belapectin 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
